Literature DB >> 8205529

A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.

K Ichimura1, E E Schmidt, N Yamaguchi, C D James, V P Collins.   

Abstract

Deletions of the 9p-localized type-I interferon (IFN) genes and adjacent loci often occur during the development of malignant glioma. We have applied restriction fragment length polymorphism and microsatellite analysis to 12 loci covering this region of 9p and 3 loci on 9q in 74 human glial tumor tissues to define and further localize the smallest region of hemizygous or homozygous deletion common to the tumors. Three regions of homozygous deletion were evident among the panel of tumors; only one of these, however, residing between D9S171 and the IFN alpha/omega gene cluster, was involved in multiple cases (13 glioblastomas). Hemizygous deletion of this same region was observed in an additional 27 tumors. In total these data indicate the frequent inactivation of a novel tumor suppressor gene residing adjacent to and centromeric of the type-I IFN genes in malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205529

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma.

Authors:  Kaishi Satomi; Makoto Ohno; Yuko Matsushita; Masamichi Takahashi; Yasuji Miyakita; Yoshitaka Narita; Koichi Ichimura; Akihiko Yoshida
Journal:  Mod Pathol       Date:  2020-10-19       Impact factor: 7.842

Review 2.  Genetic alterations in gliomas.

Authors:  V P Collins
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

Authors:  J K Lander; H Fan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.

Authors:  T Moulton; G Samara; W Y Chung; L Yuan; R Desai; M Sisti; J Bruce; B Tycko
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

5.  Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

Authors:  Lu Liu; L Magnus Bäcklund; Bo R Nilsson; Dan Grandér; Koichi Ichimura; Helena M Goike; V Peter Collins
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

6.  Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.

Authors:  E E Schmidt; K Ichimura; K R Messerle; H M Goike; V P Collins
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.

Authors:  A Miyakawa; K Ichimura; E E Schmidt; S Varmeh-Ziaie; V P Collins
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.

Authors:  Rajani Rajbhandari; Braden C McFarland; Ashish Patel; Magda Gerigk; G Kenneth Gray; Samuel C Fehling; Markus Bredel; Nicolas F Berbari; Hyunsoo Kim; Margaret P Marks; Gordon P Meares; Tanvi Sinha; Jeffrey Chuang; Etty N Benveniste; Susan E Nozell
Journal:  Oncotarget       Date:  2015-07-10

9.  Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.

Authors:  K L Marsh; J M Varley
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.